Pleural effusion is the abnormal accumulation of fluid in the pleural space between the visceral and parietal pleurae, resulting from imbalances in hydrostatic, oncotic, or lymphatic pressures or from increased capillary permeability.

Pleural Effusion

2. Epidemiology

3. Anatomy and Physiology of the Pleura

4. Etiology and Pathophysiology

This is the most fundamental classification. Every pleural effusion should be categorized as transudative or exudative because it completely changes your differential and management ^[1]^[2].

Feature	Transudative	Exudative
Mechanism	Imbalance in Starling forces (↑hydrostatic or ↓oncotic pressure)	Pleural inflammation → ↑capillary permeability or ↓lymphatic drainage
Pleural surface	Normal (no inflammation)	Abnormal (inflamed, infiltrated, or obstructed)
Laterality	Usually bilateral	Can be unilateral or bilateral
Underlying problem	Systemic	Local (lung, pleura, or adjacent organ)

4.2 Transudative Causes (with Pathophysiology)

Cause	Pathophysiology	HK Relevance
Congestive heart failure (most common overall)	Left heart failure → ↑pulmonary venous pressure → ↑hydrostatic pressure in visceral pleural capillaries → fluid leaks into pleural space. Right heart failure → ↑systemic venous pressure → ↑hydrostatic pressure in parietal pleural capillaries. Biventricular failure → bilateral effusions (R > L because of greater right-sided pulmonary venous drainage area)	Very common; ageing population
Renal failure / fluid overload	↑total body water → ↑hydrostatic pressure everywhere	Common in CKD patients
Constrictive pericarditis	Impaired diastolic filling → ↑systemic venous pressure → behaves like RHF	Rare but must consider

Why is CHF-related effusion often right-sided or bilateral (R > L)? The right lung has a greater pleural surface area. Additionally, in left heart failure, the right pulmonary veins are more immediately affected by the left atrial pressure, and the pleural lymphatics drain through the right lymphatic duct.

Cause	Pathophysiology	HK Relevance
Hepatic cirrhosis	↓hepatic albumin synthesis → hypoalbuminaemia → ↓oncotic pressure → transudation. ALSO: hepatic hydrothorax = direct passage of ascitic fluid through diaphragmatic defects (usually right-sided)	Very important in HK (HBV-related cirrhosis)
Nephrotic syndrome	Massive proteinuria → hypoalbuminaemia → ↓oncotic pressure	Common
Severe malnutrition / protein-losing enteropathy	↓albumin intake or ↑GI losses → hypoalbuminaemia	Less common

4.3 Exudative Causes (with Pathophysiology)

Cause	Pathophysiology	HK Relevance
Infection: Parapneumonic effusion / empyema	Pneumonia → inflammation of adjacent visceral pleura → ↑capillary permeability → exudative effusion. Untreated → bacteria invade pleural space → complicated parapneumonic effusion → empyema	Very common
Infection: TB pleuritis	Primary TB or reactivation → TB bacilli reach pleura → delayed-type hypersensitivity (Type IV) reaction → intense lymphocytic inflammation → protein-rich exudative effusion. Often the effusion is the immune response rather than direct infection	Very important in HK — TB remains a leading cause of lymphocytic exudative effusion
Malignant pleural effusion (MPE)	Tumour cells invade pleura → inflammation, ↑capillary permeability, and obstruction of pleural lymphatic drainage by tumour deposits. Common primaries: lung (most common), breast, lymphoma, ovary, GI	Lung cancer is the #1 cancer killer in HK
Connective tissue disease	SLE → immune complex deposition in pleura → serositis (pleuritis). RA → rheumatoid nodules on pleura → granulomatous inflammation	SLE common in young Chinese women
Pulmonary embolism (PE)	Lung infarction → ischaemic necrosis of pleura → exudative effusion. Can also cause transudative effusion via ↑RV afterload → ↑hydrostatic pressure	Important to consider in immobile patients
Pancreatitis	Pancreatic enzyme-rich fluid (amylase-rich) tracks through the aortic/oesophageal hiatus or transdiaphragmatic lymphatics → left-sided pleural effusion	Ask about alcohol and gallstones
Subphrenic / liver abscess	Adjacent inflammation → reactive effusion. Amoebic liver abscess can rupture through diaphragm	Consider in HK — amoebic abscess in returning travellers
Post-cardiac surgery / Dressler syndrome	Autoimmune response to pericardial injury → pleuropericarditis → exudative effusion (may be haemorrhagic)	Iatrogenic

Cause	Pathophysiology
Malignant infiltration of mediastinal/pleural lymphatics	Tumour blocks lymphatic stomata on parietal pleura or mediastinal lymph nodes → ↓reabsorption → effusion accumulates
Chylothorax	Disruption of the thoracic duct (trauma, surgery, lymphoma → most common non-traumatic cause) → chyle leaks into pleural space. Pleural fluid appears milky, triglycerides > 1.24 mmol/L (> 110 mg/dL)
Yellow nail syndrome	Rare triad: yellow nails + lymphoedema + pleural effusion. Due to congenital lymphatic hypoplasia → ↓lymphatic drainage

Cause	Mechanism
Haemothorax	Chest trauma → laceration of intercostal vessels, lung parenchyma, or great vessels → blood accumulates in pleural space
Post-thoracic surgery	Direct pleural disruption + inflammatory response
Central line insertion	Inadvertent puncture of subclavian/internal jugular vein → fluid (or blood) tracks into pleural space
Oesophageal rupture (Boerhaave syndrome)	Full-thickness tear → mediastinal contents and gastric fluid leak into pleural space (usually left-sided). High amylase (salivary origin)

Hong Kong High-Yield Causes

For exams, the causes you must know cold for Hong Kong practice are:

CHF (most common transudative)
TB pleuritis (most important exudative in HK — always consider in young patient with lymphocytic effusion + high ADA)
Malignant pleural effusion (lung cancer #1 in HK)
Parapneumonic effusion / empyema (common on surgical and medical wards)
Hepatic hydrothorax (HBV-driven cirrhosis)

5. Classification

The Light's criteria remain the gold standard to distinguish transudative from exudative effusions ^[1]^[2]:

An effusion is exudative if any ONE of the following is met:

Criterion	Cutoff
Pleural fluid protein / serum protein	> 0.5
Pleural fluid LDH / serum LDH	> 0.6
Pleural fluid LDH	> 2/3 upper limit of normal for serum LDH

If none of the above are met → transudative

Light's Criteria Pitfall

Light's criteria misclassify approximately 25% of transudates as exudates, particularly in patients on diuretics (who have had their serum protein concentrated by diuresis). If Light's criteria suggest exudate but you strongly suspect transudate (e.g., known CHF on diuretics), calculate the serum-to-pleural-fluid albumin gradient:

Serum albumin − pleural fluid albumin > 12 g/L → likely transudate despite meeting Light's criteria This is called the "albumin gradient correction" and is a common exam trap.

Pattern	Suggests
Bilateral	Systemic cause (transudative): CHF, hypoalbuminaemia, renal failure
Unilateral — Right	CHF (if unilateral), hepatic hydrothorax (diaphragmatic defects are R-sided), subphrenic abscess
Unilateral — Left	TB (can be either side), pancreatitis (left-sided due to anatomical proximity to pancreatic tail), aortic dissection/rupture, oesophageal rupture (Boerhaave)
Either side	Malignancy, TB, parapneumonic

Appearance	Suggests
Clear / straw-coloured	Transudate or simple exudate
Turbid / cloudy	Infection (complicated parapneumonic effusion)
Frankly purulent	Empyema
Milky / opalescent	Chylothorax (triglycerides > 110 mg/dL) or pseudochylothorax (cholesterol crystals, chronic effusion)
Bloody (haemorrhagic)	Malignancy, PE with infarction, trauma, post-cardiac surgery. If haematocrit > 50% of peripheral → haemothorax
Brown / dark	Old blood (chronic haemothorax), amoebic rupture ("anchovy sauce")
Food particles	Oesophageal rupture

This is a key classification for management decisions (particularly whether to insert a chest drain):

Stage	Definition	Pathogenesis	Pleural Fluid
1. Uncomplicated (Simple)	Free-flowing, sterile effusion	Exudative phase: Pneumonia → visceral pleural inflammation → ↑capillary permeability → sterile fluid accumulates	pH > 7.2, glucose > 2.2 mmol/L, no organisms
2. Complicated	Infected effusion without frank pus	Fibrinopurulent phase: Bacteria invade pleural space → inflammation → fibrin deposition → loculations form	pH < 7.2, glucose < 2.2 mmol/L, +ve Gram stain/culture
3. Empyema	Frank pus in pleural space	Pus accumulates, may have thick fibrinous "peel"	Overtly purulent, organisms usually present
4. Organized / Trapped lung	Fibrous peel encases the lung	Organized phase: Fibroblast proliferation → thick fibrous cortex ("peel") prevents lung re-expansion	Chronic, may be sterile

Why does pH drop? Bacteria metabolize glucose anaerobically → produce lactic acid and CO₂ → ↓pH. Neutrophils also consume glucose and release LDH. So low pH + low glucose + high LDH = bacterial activity within the pleural space.

6. Clinical Features

Symptom	Pathophysiological Basis
Dyspnoea (most common symptom)	Large effusion → compresses underlying lung → ↓functional lung volume → V/Q mismatch. Also alters chest wall and diaphragmatic mechanics → ↑work of breathing. The degree of dyspnoea depends on effusion size, rate of accumulation, and underlying cardiopulmonary reserve ^[1]^[2]
Pleuritic chest pain	Inflammation of the parietal pleura (which has somatic innervation via intercostal nerves). Sharp, stabbing, worse on inspiration (because inspiration stretches the inflamed parietal pleura). Typically indicates an exudative cause (infection, PE, CTD). Paradoxically, the pain may improve as the effusion enlarges because the fluid separates the inflamed pleural surfaces so they no longer rub against each other ^[1]^[2]
Referred shoulder tip pain	Irritation of the central diaphragmatic parietal pleura → pain referred via the phrenic nerve (C3–5) to the ipsilateral shoulder ("C3, 4, 5 keeps the diaphragm alive" — and sends pain signals to the shoulder)
Cough	Dry, non-productive cough due to compression of airways by the effusion and/or stimulation of pleural nerve endings. If productive → consider underlying pneumonia
Constitutional symptoms	Weight loss, night sweats, fever → suggest TB, malignancy, or empyema as the underlying cause
Symptoms of underlying cause	Orthopnoea/PND (CHF), haemoptysis (PE, lung cancer), joint pain/rash (SLE, RA), abdominal distension (cirrhosis with ascites), bone pain (metastatic disease)

The classical examination findings of a pleural effusion form a recognizable pattern. Understanding why each sign occurs is essential:

Sign	Pathophysiological Basis
Tracheal deviation (away from affected side)	Only with massive effusion (typically > 1.5–2 L). The accumulated fluid acts as a space-occupying lesion → pushes the mediastinum contralaterally. If the trachea deviates toward the effusion, suspect associated lung collapse (e.g., obstructive tumour with distal collapse) or trapped lung
Reduced chest wall expansion (on affected side)	Fluid restricts the mechanical movement of the ipsilateral hemidiaphragm and chest wall → splinting. The lung cannot expand as freely because it is compressed
Stony dull percussion note	Fluid is denser than air-filled lung → transmits percussion waves differently, producing a "stony" or "flat" dullness. This is distinct from the dull note of consolidation (which is less absolute because some air remains in the alveoli). The dullness shifts with patient position if the effusion is free-flowing (shifting dullness)
Decreased or absent breath sounds	The fluid layer between the chest wall and the lung acts as an acoustic barrier → sound from the lung parenchyma is attenuated before it reaches your stethoscope
Decreased vocal resonance	Same mechanism as decreased breath sounds — fluid dampens the transmission of low-frequency sound. This is a key distinguishing point from consolidation, where vocal resonance is increased (because the solid, consolidated lung transmits sound better than normal air-filled lung) ^[1]
Decreased tactile vocal fremitus	Fluid dampens the vibrations that are normally transmitted from the larynx through the lung parenchyma to the chest wall. A fluid barrier blocks this transmission
Aegophony (E→A change at the upper border)	At the junction of effusion and aerated lung, the effusion acts as a low-pass filter — it preferentially transmits lower-frequency sounds. When the patient says "E" (higher frequency), it sounds like "A" (lower frequency) at the stethoscope. This is heard at the upper border of the effusion
Bronchial breathing above the effusion	At the upper border of the effusion, the compressed (but still aerated) lung conducts sound efficiently, mimicking consolidation → producing bronchial breathing
Ewart's sign	Dullness to percussion and bronchial breathing at the left inferior angle of the scapula — classically described in large pericardial effusion where the enlarged pericardial sac compresses the left lower lobe, but can also occur with large left-sided pleural effusion ^[4]

Examination Pattern: Pleural Effusion vs Consolidation vs Pneumothorax

Feature	Pleural Effusion	Consolidation	Pneumothorax
Percussion	Stony dull	Dull	Hyper-resonant
Breath sounds	↓↓ or absent	Bronchial	↓↓ or absent
Vocal resonance	↓↓	↑↑ (+ whispering pectoriloquy)	↓↓
Tactile fremitus	↓↓	↑↑	↓↓
Trachea	Away (if massive)	Central (usually)	Away (if tension)
Added sounds	None (or aegophony at top)	Coarse crackles	None

This table is extremely high yield for clinical exams.

Always look for clues to the aetiology — this is what examiners want to see:

Sign	Suggests
Bilateral pitting oedema, ↑JVP, hepatomegaly, displaced apex	Heart failure
Spider naevi, palmar erythema, jaundice, ascites, gynaecomastia	Cirrhosis
Clubbing, cachexia, lymphadenopathy, Horner syndrome	Lung cancer
Cachexia, night sweats, lymphadenopathy	TB or lymphoma
Butterfly rash, oral ulcers, arthritis, alopecia	SLE
Rheumatoid hands, subcutaneous nodules	RA
Unilateral calf swelling, Wells score features	DVT → PE
Periorbital oedema, frothy urine history	Nephrotic syndrome

7. Relevant Imaging Features (Pre-Diagnosis Section)

Finding	Details
Blunting of costophrenic (CP) angle	Earliest sign on erect CXR. Requires ≥175 mL of fluid to blunt the posterior CP angle (lateral film) or ≥200 mL for the lateral CP angle on PA film ^[1]^[5]
Meniscus sign	The fluid level curves upward at the lateral chest wall due to capillary action and surface tension. This concave upper border is characteristic of a free-flowing effusion
White-out of hemithorax	Massive effusion → complete opacification of the hemithorax
Lateral decubitus film	Patient lies on the affected side → free-flowing fluid layers dependently. Minimum 100 mL detectable. > 1 cm thickness on lateral decubitus film = amenable to pleural tapping. If fluid does NOT redistribute → loculated effusion ^[1]
Estimating volume	CP angle blunting ≈ 175 mL; lower 1/3 ≈ 1 L; lower 1/2 ≈ 2 L ^[1]

8. Pleural Fluid Analysis Overview

This section outlines what you send for and why — the actual diagnostic algorithm and criteria will follow in the next response.

Test	Purpose
Appearance	Straw, turbid, milky, bloody, purulent (see classification above)
Biochemistry: Protein, LDH	Light's criteria (requires simultaneous serum protein + LDH)
pH	< 7.2 suggests complicated parapneumonic effusion/empyema, or oesophageal rupture, or RA
Glucose	< 2.2 mmol/L → empyema, RA, TB, malignancy, oesophageal rupture
Adenosine deaminase (ADA)	> 30 IU/L suggests TB (very useful in HK). ADA is released by activated T-lymphocytes in the granulomatous response ^[1]
Amylase	Elevated in pancreatitis (pancreatic amylase) or oesophageal rupture (salivary amylase)
Triglycerides	> 1.24 mmol/L (110 mg/dL) → chylothorax
Cell count + differential	Lymphocyte-predominant → TB, malignancy, sarcoidosis. Neutrophil-predominant → parapneumonic, PE. Eosinophilic (> 10%) → blood/air in pleural space, drug reaction, parasites, asbestos
Microbiology: Gram stain, AFB smear, bacterial culture, TB culture, MTB-PCR, ± fungal culture	Identify infectious organisms ^[1]
Cytology (20 mL × 3)	If malignancy suspected. Three separate samples increase sensitivity to ~60–70%. If negative but suspicion remains → consider pleural biopsy ^[1]

ADA in TB Pleuritis

Adenosine deaminase (ADA) > 30–40 IU/L in a lymphocytic effusion has a sensitivity of ~90% and specificity of ~92% for TB pleuritis. This is particularly useful in Hong Kong where TB is common. ADA is an enzyme involved in purine metabolism, released by activated T-lymphocytes — it reflects the intense cell-mediated (Type IV) immune response against TB. A low ADA ( < 30) in an immunocompetent patient effectively rules out TB pleuritis ^[1].

Indicated when pleural fluid analysis is non-diagnostic, especially in suspected TB or malignancy:

Method	Details
Bedside percutaneous (Abram's needle)	First-line in HK where TB is common; obtains parietal pleural tissue. Good for TB (granulomas are diffusely distributed on pleura). Poor sensitivity for malignancy (tumour deposits may be focal and missed by blind biopsy) ^[1]
Image-guided (TEMNO needle)	USG or CT-guided → more precise targeting of pleural thickening/nodules
Medical thoracoscopy / pleuroscopy	Semi-invasive procedure under IV sedation (not GA). Allows visualization + biopsy + drainage + pleurodesis in one procedure → very efficient ^[1]
VATS (video-assisted thoracoscopic surgery)	Requires general anaesthesia + single-lung ventilation. Most definitive but most invasive. Reserved for cases needing surgical intervention or when medical thoracoscopy fails ^[1]

9. Special Pleural Effusion Subtypes (Focused Clinical Context)

Definition: Accumulation of chyle in the pleural space
Mechanism: Disruption of the thoracic duct → chyle (rich in dietary long-chain triglycerides absorbed by intestinal lacteals) leaks into the mediastinum and then into the pleural space
Causes: Trauma/surgical (most common — post-oesophagectomy, post-cardiac surgery), lymphoma (most common non-traumatic cause), other malignancies, sarcoidosis
Diagnostic: Pleural fluid triglycerides > 1.24 mmol/L (110 mg/dL), milky appearance, chylomicrons present on lipoprotein analysis

High Yield Summary

Definition: Pleural effusion = pathological accumulation of fluid in the pleural space. Always determine the cause.

Key anatomy: Parietal pleura has somatic innervation (intercostal nerves, phrenic nerve) → pain. Visceral pleura has no somatic innervation → painless. Lymphatic stomata on parietal pleura are the main route of fluid drainage.

Pathophysiology — 4 determinants: Hydrostatic pressure, oncotic pressure, capillary permeability, lymphatic drainage.

Classification:

Transudative (systemic, bilateral): CHF, cirrhosis, nephrotic syndrome, renal failure
Exudative (local, unilateral/bilateral): TB, parapneumonic/empyema, malignancy, PE, CTD, pancreatitis
Light's criteria: Exudate if pleural:serum protein > 0.5, pleural:serum LDH > 0.6, or pleural LDH > 2/3 ULN serum LDH
Albumin gradient correction if on diuretics: serum − pleural albumin > 12 g/L → transudate

Hong Kong focus: TB pleuritis (ADA > 30, lymphocytic), lung cancer MPE, HBV-related cirrhosis (hepatic hydrothorax)

Clinical signs: Stony dull percussion, ↓breath sounds, ↓vocal resonance, ↓tactile fremitus, tracheal deviation away (if massive), meniscus sign on CXR

Parapneumonic staging: Uncomplicated → Complicated (pH < 7.2, glucose < 2.2) → Empyema (pus) → Organized/Trapped lung

Imaging: CXR (≥175 mL to detect), USG (most sensitive bedside), CT for complex cases. Lateral decubitus film: > 1 cm = tappable.

Pleural fluid: Appearance, biochemistry (Light's criteria, pH, glucose, ADA, amylase, TG), cell count + differential, micro (Gram, AFB, culture, PCR), cytology (20 mL × 3)

Pleural biopsy: Abram's needle first-line for TB in HK; medical thoracoscopy allows biopsy + drainage + pleurodesis

Active Recall - Pleural Effusion (Definition, Epidemiology, Etiology, Clinical Features)

Differential Diagnosis of Pleural Effusion

A. Differential Diagnosis by Transudative vs. Exudative Category

The pleural surfaces are normal. The fluid accumulates because Starling forces are deranged systemically. Usually bilateral ^[1]^[2]^[3].

Cause	Key Distinguishing Clues	Why It Causes Effusion
Congestive heart failure (most common cause overall)	Bilateral effusion (R > L), cardiomegaly on CXR, ↑JVP, bilateral pitting oedema, orthopnoea/PND, ↑BNP/NT-proBNP, pulmonary congestion signs (Kerley B lines, upper lobe venous diversion) ^[6]	↑pulmonary venous hydrostatic pressure (LHF) + ↑systemic venous hydrostatic pressure (RHF) → fluid pushed out of parietal and visceral pleural capillaries into the pleural space
Hepatic cirrhosis / Hepatic hydrothorax	Usually right-sided (85%), ascites present, stigmata of chronic liver disease (spider naevi, palmar erythema, gynaecomastia, jaundice), low serum albumin ^[7]	Two mechanisms: (1) ↓oncotic pressure from hypoalbuminaemia; (2) direct passage of ascitic fluid through diaphragmatic defects (fenestrations, usually right-sided) driven by positive intra-abdominal pressure and negative intrathoracic pressure
Nephrotic syndrome	Periorbital or generalised oedema, frothy urine, serum albumin < 30 g/L, heavy proteinuria > 3.5 g/day, hyperlipidaemia ^[8]	↓oncotic pressure from massive urinary albumin loss → fluid transudation across capillaries including pleural capillaries
Renal failure / fluid overload	History of CKD, fluid overload, elevated creatinine, bilateral effusions, peripheral oedema	↑total body water → ↑hydrostatic pressure + ↓oncotic pressure (if concurrent hypoalbuminaemia)
Constrictive pericarditis	↑JVP with Kussmaul sign (paradoxical ↑JVP on inspiration), pericardial knock, calcified pericardium on CXR/CT, Friedreich sign (prominent y descent) ^[1]	Impaired diastolic filling of both ventricles → ↑systemic and pulmonary venous pressures → bilateral transudative effusion
Peritoneal dialysis	History of PD, sudden onset of unilateral (usually right) effusion, fluid has same glucose concentration as PD dialysate ^[1]	Pleuroperitoneal fistula — dialysate crosses through congenital or acquired diaphragmatic defects into the pleural space
Protein-losing enteropathy	Chronic diarrhoea, peripheral oedema, low serum albumin, elevated faecal α₁-antitrypsin ^[1]	↓oncotic pressure from GI protein loss
Myxoedema (severe hypothyroidism)	Periorbital oedema, dry/coarse skin, bradycardia, delayed relaxation reflexes, ↑TSH ^[9]	↑capillary permeability from mucopolysaccharide deposition + ↓lymphatic clearance. Often serous effusions in multiple cavities (pericardial, pleural, ascites)
Meigs' syndrome	Ovarian mass (fibroma/thecoma) + ascites + right-sided pleural effusion, resolves after tumour resection	Tumour produces peritoneal fluid → crosses diaphragmatic lymphatics → pleural effusion. Despite being associated with a tumour, the effusion itself is a transudate

Bilateral Effusion ≠ Always Transudative

While bilateral effusions strongly suggest a transudative cause, bilateral exudative effusions do occur — for example, bilateral malignant pleural effusions (especially in lymphoma or extensive pleural metastases), bilateral TB pleuritis, or bilateral parapneumonic effusions in bilateral pneumonia. Always tap if there are atypical features (asymmetry, fever, failure to respond to diuresis) ^[1]^[3].

Exudative Effusion — "The Problem is Local"

The pleural surfaces are inflamed, infiltrated, or the lymphatic drainage is obstructed. Can be unilateral or bilateral ^[1]^[2]^[3].

Cause	Key Distinguishing Clues	Why It Causes Effusion
Parapneumonic effusion / Empyema	Adjacent pneumonia, fever, productive cough, leukocytosis. Fluid: neutrophilic, ↓pH ( < 7.2) and ↓glucose ( < 2.2 mmol/L) if complicated; overtly purulent if empyema ^[1]	Pneumonia → inflammation of adjacent visceral pleura → ↑capillary permeability → sterile exudative effusion (uncomplicated). Bacteria invade → fibrinopurulent stage → complicated effusion → empyema (pus)
TB pleuritis	Young patient (in HK), constitutional symptoms (fever, night sweats, weight loss), contact history. Fluid: lymphocyte-predominant, protein > 4 g/dL, ADA > 30–40 IU/L, low glucose ^[1]^[2]^[3]	TB bacilli reach subpleural focus → rupture into pleural space → Type IV hypersensitivity → intense lymphocytic inflammation. Organisms are often scarce (AFB smear +ve in < 10%) because the effusion is predominantly an immune response
Viral pleuritis	Self-limiting, associated with viral URTI, younger patients, small effusion	Direct viral inflammation of pleural mesothelial cells → ↑capillary permeability

Cause	Key Distinguishing Clues	Why It Causes Effusion
Malignant pleural effusion (MPE) — lung (most common), breast, lymphoma, ovary, gastric (with dyspnoea due to pleural effusion or lymphangitis) ^[1]^[10]	Older patient, smoking history (lung CA), weight loss, cachexia, clubbing, lymphadenopathy. Fluid: often bloody/haemorrhagic, lymphocyte-predominant, cytology positive in ~60% (1 tap). Metastatic gastric cancer may present with dyspnoea from pleural effusion ^[10]	(1) Tumour cells invade pleura → ↑capillary permeability; (2) tumour deposits obstruct parietal pleural lymphatic stomata and mediastinal lymph nodes → ↓lymphatic drainage → fluid accumulates. Often large, rapidly re-accumulating
Malignant mesothelioma	History of asbestos exposure (> 40 years prior), unremitting chest pain, pleural thickening/mass on CT, unilateral effusion ^[5]	Malignant transformation of pleural mesothelial cells → ↑permeability + lymphatic obstruction. Biopsy required for definitive diagnosis
Lymphoma (Hodgkin or NHL)	Mediastinal lymphadenopathy, B symptoms (fever > 38°C, night sweats, weight loss > 10%/6 months), pericardial/pleural effusion especially in bulky mediastinal disease ^[11]	Mediastinal nodal involvement → obstruction of lymphatic drainage; direct pleural infiltration; or chylothorax from thoracic duct obstruction

Cause	Key Distinguishing Clues	Why It Causes Effusion
Rheumatoid arthritis (RA)	Rheumatoid hands, subcutaneous nodules, predominantly male (unlike RA itself), unilateral. Fluid: very low glucose ( < 1.6 mmol/L — classically the lowest of all causes), low pH, ↑LDH > 1000 IU/L, high cholesterol. May persist for years ^[1]^[3]	Rheumatoid nodules on pleural surface → granulomatous inflammation → ↑capillary permeability + impaired glucose transport across inflamed pleura. RA pleural fluid glucose can be strikingly low — lower than any other cause
SLE	Young female, butterfly rash, oral ulcers, arthritis, alopecia, serositis (pleuritis/pericarditis). Bilateral in ~50%. Fluid: lymphocytic or neutrophilic, low complement, +ve ANA/anti-dsDNA in fluid ^[1]^[12]	Immune complex deposition in pleural capillaries → complement activation → serositis → ↑capillary permeability
Pancreatitis	Epigastric pain radiating to back, history of gallstones or alcohol. Effusion usually left-sided. Fluid: very high amylase (pancreatic isoenzyme), often bloody ^[1]	Pancreatic enzyme-rich inflammatory fluid tracks from the retroperitoneum through the aortic/oesophageal hiatus or transdiaphragmatic lymphatics into the pleural space. Left-sided because the pancreatic tail is anatomically left-sided

Cause	Key Distinguishing Clues	Why It Causes Effusion
Pulmonary embolism (PE)	Acute pleuritic chest pain, dyspnoea, haemoptysis, tachycardia, DVT signs, risk factors for VTE (immobility, surgery, malignancy). ECG: sinus tachycardia, S1Q3T3 ^[13]	(1) Lung infarction → ischaemic necrosis of pleura → exudative effusion (most common mechanism); (2) ↑RV afterload → ↑hydrostatic pressure → transudative effusion. PE can cause either transudative or exudative effusion — this is an exam favourite
Haemothorax	History of chest trauma, recent thoracic surgery, anticoagulation. Fluid: frankly bloody, pleural fluid haematocrit > 50% of peripheral blood haematocrit ^[1]	Laceration of intercostal vessels, lung parenchyma, or great vessels → blood accumulates in the pleural space
Chylothorax	History of thoracic surgery (especially oesophagectomy), lymphoma, trauma. Fluid: milky/opalescent, triglycerides > 1.24 mmol/L (110 mg/dL), chylomicrons present ^[1]^[2]	Disruption or obstruction of the thoracic duct → chyle leaks into mediastinum then pleural space
Oesophageal rupture (Boerhaave syndrome)	Severe vomiting → excruciating chest pain, surgical emphysema (Mackler's triad). Usually left-sided. Fluid: very low pH, very high salivary amylase, may contain food particles ^[14]	Full-thickness tear (most commonly left posterolateral distal oesophagus) → gastric contents and oral secretions leak into mediastinum and left pleural space
Aortic dissection	Sudden severe tearing pain maximal at onset, BP differential between arms, widened mediastinum on CXR. Left pleural effusion in 19% ^[15]	Rupture or leakage of blood from the aortic false lumen into the left pleural space → haemothorax

Cause	Key Distinguishing Clues	Why It Causes Effusion
Post-thoracic surgery	Recent thoracic or cardiac surgery, Dressler syndrome (autoimmune pleuropericarditis post-MI or post-cardiac surgery) ^[1]	Direct pleural disruption + inflammatory response; or autoimmune mechanism (Dressler)
Drug-induced	Temporal relationship with drug initiation (e.g., methotrexate, amiodarone, nitrofurantoin, dasatinib, phenytoin)	Drug-induced pleuritis or hypersensitivity reaction → ↑capillary permeability
Subphrenic / liver abscess	Fever, RUQ pain, hepatomegaly. Reactive effusion usually right-sided, sympathetic (sterile) ^[1]	Adjacent inflammation → reactive effusion. If amoebic abscess ruptures through diaphragm → may see "anchovy sauce" fluid

B. Differential Diagnosis Guided by Pleural Fluid Findings

This is the practical, exam-oriented way to narrow the differential once you have the pleural fluid results. The senior notes frame this nicely ^[1]:

Pleural Fluid Finding	Differential Diagnosis	Pathophysiological Reasoning
Low pH ( < 7.2) / Low glucose ( < 2.2 mmol/L)	Empyema, complicated parapneumonic effusion, malignancy, TB, RA/SLE, oesophageal rupture ^[1]^[3]	Bacteria/WBCs/tumour cells consume glucose via anaerobic glycolysis → ↑lactic acid + CO₂ → ↓pH. In RA, impaired glucose transport across thickened pleura also contributes
↑↑LDH > 1000 IU/L	Empyema, malignancy, RA, paragonimiasis ^[1]	Very high LDH reflects massive cell turnover/necrosis within the pleural space. In empyema = neutrophil lysis; in malignancy = tumour cell necrosis; in RA = chronic intense granulomatous inflammation
↑Amylase	Pancreatitis, malignancy, oesophageal rupture ^[1]	Pancreatitis: pancreatic amylase leaks into pleural space. Oesophageal rupture: salivary amylase from oral/oesophageal secretions enters pleural space. Some malignancies (lung, ovarian) can produce ectopic amylase
Bloody / haemorrhagic fluid	Malignancy, TB, PE, trauma ^[1]^[3]	Malignancy: tumour neovascularisation + direct vascular invasion. TB: intense granulomatous inflammation damages capillaries. PE: pulmonary infarction → necrosis with bleeding. Trauma: direct vascular injury
Cholesterol > 4 g/dL or Triglycerides > 110 mg/dL	Chylothorax (high TG): lymphatic obstruction (lymphoma), lymphatic damage post-surgery, nephrotic syndrome, cirrhosis ^[1]	Chylothorax: TG > 110 mg/dL from thoracic duct disruption. Pseudochylothorax (cholesterol effusion): high cholesterol in long-standing effusions where cholesterol crystals precipitate from degenerating cell membranes

Cell Pattern	Differential Diagnosis	Why
Neutrophil predominant	Acute processes: parapneumonic effusion, PE, acute pancreatitis, early TB, subphrenic abscess ^[2]^[3]	Neutrophils are first responders to acute infection/inflammation — they arrive within hours of the insult
Lymphocyte predominant	Chronic processes: TB (most important in HK), malignancy, lymphoma, sarcoidosis, RA, post-CABG ^[2]^[3]	Lymphocytes predominate in chronic inflammation (T-cell mediated immunity in TB, chronic tumour-immune interaction in malignancy). In HK, lymphocytic effusion = TB until proven otherwise
Eosinophilic ( > 10%)	Blood or air in pleural space, drug reaction, parasitic disease (e.g., paragonimiasis), asbestos-related benign pleural effusion, Churg-Strauss/EGPA	Eosinophils are recruited by cytokines released in response to blood/air irritation, parasitic antigens, or allergic/eosinophilic conditions

Exam Favourite: What Causes Bloody Pleural Effusion?

Think of the mnemonic "STAMP" — though not perfect, it captures the key causes:

S = Surgery / Trauma (haemothorax)
T = TB
A = Asbestos-related (benign effusion or mesothelioma)
M = Malignancy (most common cause of bloody effusion)
P = PE (pulmonary infarction)

If pleural fluid haematocrit > 50% of peripheral → this is a true haemothorax and requires chest drain ± surgical management, not just diagnostic evaluation.

On CXR, a pleural effusion (area of whiteness at the lung base) can be mimicked by other pathologies. You must consider these in your radiological differential ^[3]^[4]:

CXR Finding	True Effusion	Mimics and How to Distinguish
White-out at lung base	Homogeneous opacity, meniscus sign, blunted CP angle, no air bronchograms, mediastinal shift away (if massive) ^[3]^[4]	Consolidation: air bronchograms present, no meniscus, dull but not stony dull percussion. Collapse/atelectasis: mediastinal shift toward the opacity, volume loss signs. Elevated hemidiaphragm: smooth dome, can trace diaphragm contour, no meniscus. Pleural thickening: same density as chest wall muscle (not darker), does not shift with position

This table is extremely high yield for clinical exams and SAQs. It distils the most important discriminating features for the commonest causes:

Feature	CHF	TB Pleuritis	Malignancy	Parapneumonic / Empyema	PE	RA
Laterality	Bilateral (R > L)	Unilateral	Unilateral	Unilateral (adjacent to pneumonia)	Unilateral	Unilateral
Light's	Transudate	Exudate	Exudate	Exudate	Either	Exudate
Appearance	Straw	Straw/bloody	Bloody/straw	Turbid → purulent	Bloody/straw	Greenish-yellow
pH	> 7.4	< 7.3	< 7.3 (poor prognostic sign)	< 7.2 (complicated)	> 7.3	Very low ( < 7.2)
Glucose	Normal	Low	Low	Very low ( < 2.2)	Normal	Very low ( < 1.6)
LDH	Low	Moderate	Moderate-high	Very high ( > 1000 in empyema)	Moderate	Very high ( > 1000)
Cells	Few mesothelial	Lymphocytes	Lymphocytes	Neutrophils	Neutrophils/mixed	Mixed
ADA	Low	> 30–40	Low-normal	Variable	Low	Can be elevated
Special	↑BNP, cardiomegaly	AFB culture, biopsy granulomas	Cytology +ve in ~60%	Gram stain, culture	D-dimer, CTPA	RF, anti-CCP, very ↓glucose

These are rarer causes that examiners love to test because students often miss them:

Condition	Clue	Fluid Finding
Paragonimiasis (lung fluke)	Travel to endemic area (East/Southeast Asia), eosinophilia, haemoptysis	Eosinophilic effusion, ↑↑LDH > 1000, may have Paragonimus eggs
Yellow nail syndrome	Yellow dystrophic nails + lymphoedema + pleural effusion (triad). Congenital lymphatic hypoplasia	Exudative (lymphocyte-predominant), chylous in some cases
Dressler syndrome (post-cardiac injury syndrome)	2–10 weeks post-MI or post-cardiac surgery, fever, pleuritic chest pain, pericarditis	Exudative, may be haemorrhagic, ↑ESR
Ovarian hyperstimulation syndrome (OHSS)	Young woman undergoing IVF, bilateral effusions + ascites	Exudative, ↑capillary permeability from VEGF release
Drug-induced lupus	History of procainamide, hydralazine, isoniazid. +ve ANA, +ve anti-histone Ab, −ve anti-dsDNA	Exudative, similar to SLE effusion

High Yield Summary — Differential Diagnosis

Step 1 — Classify: Apply Light's criteria to every tapped effusion. If transudative → think systemic (CHF, cirrhosis, nephrotic, renal failure). If exudative → think local (infection, malignancy, inflammation).

Step 2 — Narrow by fluid profile:

Low pH/glucose → empyema, RA, TB, malignancy, oesophageal rupture
↑↑LDH > 1000 → empyema, RA, malignancy, paragonimiasis
↑Amylase → pancreatitis, oesophageal rupture, malignancy
Bloody → malignancy, TB, PE, trauma (check HCT for haemothorax)
Milky → chylothorax (TG > 110 mg/dL)

Step 3 — Narrow by cell differential:

Neutrophils → acute (parapneumonic, PE, pancreatitis)
Lymphocytes → chronic (TB, malignancy, RA/SLE)
Eosinophils → blood/air, parasites, drugs, asbestos

Hong Kong priorities: TB (ADA > 30 + lymphocytic), lung cancer MPE, CHF, HBV-cirrhosis hepatic hydrothorax

PE can cause EITHER transudative or exudative effusion — don't be caught out.

RA effusion has the lowest glucose of all causes (can be < 1.6 mmol/L) — a classic exam distinction.

Active Recall - Differential Diagnosis of Pleural Effusion

References

^[1] Senior notes: Maksim Medicine Notes.pdf (Pleural effusion section, p290-293) ^[2] Senior notes: Ryan Ho Respiratory.pdf (Section 2.4 Pleural Effusion, p24-25) ^[3] Senior notes: Ryan Ho Fundamentals.pdf (Section 3.2.4 Pleural Effusion, p227-228; Section 3.2.6.4 Pleural Shadows, p240) ^[4] Senior notes: Ryan Ho Respiratory.pdf (Section 2.6.4 Pleural Shadows, p47) ^[5] Senior notes: Ryan Ho Respiratory.pdf (Malignant Mesothelioma, p127) ^[6] Senior notes: Maksim Medicine Notes.pdf (Heart failure section, p16-18) ^[7] Senior notes: Ryan Ho GI.pdf (Hepatic hydrothorax, p314) ^[8] Senior notes: Ryan Ho Urogenital.pdf (Nephrotic syndrome, p73) ^[9] Senior notes: Ryan Ho Endocrine.pdf (Hypothyroidism features, p11) ^[10] Lecture slides: GC 212. Weight loss and vomiting gastric cancer; abdominal imaging.pdf (p26 — metastatic features of gastric cancer including dyspnoea from pleural effusion) ^[11] Senior notes: Ryan Ho Haemtology.pdf (Hodgkin lymphoma features, p94) ^[12] Senior notes: Ryan Ho Rheumatology.pdf (SLE, p69) ^[13] Senior notes: Ryan Ho Haemtology.pdf (VTE/PE features, p131) ^[14] Senior notes: Maksim Surgery Notes.pdf (Boerhaave syndrome, p59) ^[15] Senior notes: Ryan Ho Cardiology.pdf (Aortic dissection — left pleural effusion 19%, p220)

Diagnostic Criteria, Algorithm, and Investigation Modalities

B. Light's Criteria — The Cornerstone Diagnostic Tool

Light's criteria classify a pleural effusion as exudative if it meets any ONE of the following three conditions ^[1]^[2]^[3]:

Criterion	Cutoff for Exudate
Pleural fluid protein / serum protein	> 0.5
Pleural fluid LDH / serum LDH	> 0.6
Pleural fluid LDH	> 2/3 of upper limit of normal for serum LDH

If none of the three criteria are met → transudative.

Must-know principle: Pleural fluid biochemistry should always be sent together with a paired serum sample (serum protein + serum LDH) drawn at the same time. Without the serum values, you cannot calculate the ratios ^[3].

Light's criteria tend to overdiagnose exudative fluid, especially if the patient is on chronic diuretics ^[1].

Why? Diuretics remove free water → serum proteins and LDH become concentrated → pleural fluid ratios approach exudative thresholds even though the underlying process is transudative (e.g., CHF patient on furosemide).

The fix: If Light's criteria suggest exudate but the clinical picture strongly suggests transudate → calculate the serum-to-pleural-fluid albumin gradient:

Test	Interpretation
Serum albumin − pleural fluid albumin > 12 g/L	Likely transudate (misclassified by Light's)
Serum albumin − pleural fluid albumin ≤ 12 g/L	Likely true exudate

Another complementary check mentioned in the senior notes ^[1]: serum-pleural fluid protein difference < 3.1 g/dL → likely exudative (i.e., the protein levels are close together → high permeability → true exudate).

Exam Trap: Light's Criteria in Diuretic Patients

This is tested in almost every summative exam. A CHF patient on furosemide presents with a unilateral effusion. Light's criteria classify it as an exudate. Before you embark on an expensive workup for malignancy or TB, calculate the albumin gradient. If > 12 g/L → it's a diuretic-induced pseudo-exudate, and you should treat the CHF, not chase an exudative cause.

C. Extended Pleural Fluid Analysis — The Diagnostic Toolkit

Once you have classified the effusion as exudative using Light's criteria, you need to determine the specific cause. This is where the extended pleural fluid panel comes in ^[1]^[2]^[3]:

Appearance	Suggests	Pathophysiological Basis
Straw-coloured	Transudate or simple exudate	Normal pleural fluid colour; protein-rich but not contaminated
Turbid (cloudy)	Empyema or complicated parapneumonic effusion	Turbidity from high WBC count (neutrophils), debris, fibrin
Milky	Chylothorax	Chylomicrons from thoracic duct disruption scatter light → milky appearance
Bloody	Malignancy, TB, PE, trauma	Vascular disruption (tumour neovascularisation, infarction, direct injury) → RBCs leak into fluid
Brown (dark)	Old blood	Haemoglobin degradation products (methaemoglobin) in chronic haemothorax
Frankly purulent	Empyema	Massive neutrophil accumulation and necrotic debris = pus
Food particles	Oesophageal rupture	Gastric/oesophageal contents enter pleural space via perforation

Pro tip: The moment you aspirate frank pus, you don't even need to wait for biochemistry — the diagnosis is empyema and you should insert a chest drain immediately ^[1].

Test	Key Cutoffs and Interpretation	Why It Works
pH	< 7.2 → complicated parapneumonic / empyema, malignancy, TB, RA, oesophageal rupture ^[1]^[2]^[3]. Normal pleural fluid pH ≈ 7.60 (alkaline relative to blood because of active bicarbonate transport by mesothelial cells). In empyema: pH can drop to < 7.0	Bacteria/neutrophils consume glucose anaerobically → produce lactic acid + CO₂ → ↓pH. In RA: thickened pleura impairs CO₂ clearance. In malignancy: tumour metabolism + impaired pleural clearance
Glucose	< 2.2 mmol/L (or < 0.5× serum glucose or ≤ 3.33 mmol/L) → same differential as low pH ^[2]^[3]	Same organisms consuming glucose. RA has particularly low glucose (< 1.6 mmol/L) because of impaired glucose transport across thickened, inflamed synovial-like pleural tissue
ADA (adenosine deaminase)	> 30–40 IU/L suggests TB ^[1]^[2]^[3]. Note: can also be elevated in empyema, RA, and some malignancies	ADA is released by activated T-lymphocytes. In TB pleuritis, there is intense Type IV hypersensitivity → massive T-cell activation → very high ADA. The enzyme catalyses deamination of adenosine → inosine in purine metabolism
Amylase	↑amylase → pancreatitis, malignancy, oesophageal rupture ^[1]	Pancreatitis: pancreatic isoenzyme leaks via transdiaphragmatic lymphatics. Oesophageal rupture: salivary isoenzyme from oral secretions. Some malignancies (lung, ovarian) ectopically produce amylase
Triglycerides	> 1.24 mmol/L (110 mg/dL) → chylothorax. < 0.56 mmol/L (50 mg/dL) → rules out chylothorax ^[1]	Chyle from thoracic duct is rich in dietary long-chain triglycerides absorbed by intestinal lacteals
Cholesterol	> 5.18 mmol/L (200 mg/dL) or cholesterol crystals → pseudochylothorax	Long-standing effusions: cell membrane cholesterol accumulates from degenerating cells. Not thoracic duct-related
Protein (absolute)	Transudative < 3 g/dL; TB > 4 g/dL; Waldenström macroglobulinaemia/myeloma: 7–8 g/dL ^[2]	TB produces very high protein due to intense inflammatory exudation. Paraproteinaemias produce IgM/other immunoglobulins that accumulate in pleural fluid
LDH (absolute)	> 1000 IU/L → empyema, RA, some malignancy, paragonimiasis ^[1]^[2]	Very high LDH = massive cell death. In empyema: neutrophil necrosis. In RA: chronic granulomatous inflammation with cell destruction

Finding	Differential	Reasoning
Neutrophil predominant	Acute inflammation: parapneumonic effusion, PE, acute pancreatitis, early TB, subphrenic abscess ^[2]^[3]	Neutrophils are the first-response inflammatory cells — recruited within hours of acute pleural insult via IL-8 and C5a chemotaxis
Lymphocyte predominant	Chronic inflammation: TB (most important in HK), malignancy, lymphoma, RA/SLE, sarcoidosis ^[2]^[3]	T-lymphocytes dominate in chronic cell-mediated immunity (TB) and in chronic tumour-immune interactions
Eosinophilic (> 10%)	Blood or air in pleural space, drug reaction, parasitic (paragonimiasis), asbestos-related, EGPA	Eosinophils are recruited by IL-5 and eotaxin in response to parasitic antigens, foreign material (blood/air), and allergic processes
Cell count > 50,000/μL → only in complicated parapneumonic effusion. > 10,000 in parapneumonic, pancreatitis, SLE. < 5,000 in chronic exudates (TB, malignancy) ^[2]	—	Higher cell counts reflect more acute and intense inflammation
Mesothelial cells present	Absence of mesothelial cells (< 5%) → suggests TB (because the intense granulomatous pleuritis traps and destroys mesothelial cells)	Normally, desquamated mesothelial cells are present in pleural fluid. Their absence is a negative marker for TB

Test	Purpose	Key Points
Gram stain	Rapid identification of bacteria in parapneumonic/empyema	Positive Gram stain is an indication for chest drain ^[1]. Sensitivity ~60% in empyema, lower in parapneumonic
Bacterial culture (aerobic + anaerobic)	Definitive organism identification + sensitivity	Culture fluid in blood culture bottles to ↑sensitivity. Always request anaerobic culture — anaerobes (e.g., Bacteroides) are common in empyema
AFB smear	Acid-fast bacilli for TB	Low sensitivity (< 10% in TB pleuritis) because organisms are scarce — the effusion is primarily an immune response, not direct infection
TB culture (Löwenstein-Jensen / MGIT)	Definitive TB diagnosis	Gold standard but takes 2–8 weeks. Sensitivity ~30% in pleural fluid alone
MTB-PCR (e.g., GeneXpert)	Rapid molecular detection of M. tuberculosis	Faster than culture (~2 hours), also detects rifampicin resistance. Sensitivity in pleural fluid is moderate (~50–60%) — better than smear, worse than culture + biopsy combined
± Fungal culture	If immunosuppressed or endemic exposure	Consider in HIV, prolonged steroids, diabetes

Parameter	Details
Volume to send	20 mL × 3 separate samples ^[1] — larger volume ↑ yield because malignant cells may be sparse
Sensitivity	~60% with 1 tap, ~75% with 2 taps ^[3]. Third sample adds only marginal yield (~5–10%)
False-negatives	Mesothelioma (cells hard to distinguish from reactive mesothelial cells), sarcomatoid tumours, lymphoma (need flow cytometry instead)
If negative but suspicion remains	Proceed to pleural biopsy (see below)

Why Send 20 mL × 3?

Malignant cells shed from pleural tumour deposits intermittently and are often diluted in large effusion volumes. By sending three separate large-volume samples (20 mL each), you maximise the chance of capturing clusters of tumour cells. This is analogous to sending three sputum samples for AFB — sampling error is reduced by repetition ^[1]^[3].

D. Imaging Modalities — Systematic Breakdown

The first-line investigation. Always start here.

Projections:

PA erect → higher quality, accurate heart size assessment. Minimum ~175 mL of fluid to detect (blunting of CP angle) ^[1]^[5]
AP (portable) → lower quality, exaggerates heart size and mediastinal contour; used for bed-bound patients ^[5]
Lateral decubitus → patient lies on the affected side → free-flowing fluid layers dependently. Minimum ~100 mL detectable. Detects loculations (fluid does NOT redistribute on position change) ^[1]

Key CXR findings in pleural effusion ^[1]^[3]^[5]:

Finding	Significance
Blunting of costophrenic angle	Earliest sign; requires ≥ 175 mL fluid
Meniscus sign	Concave upper border of fluid curving upward laterally. Note: the fluid level is actually flat — the "meniscus" appearance occurs because X-rays pass through a thicker layer of fluid at the periphery, producing a denser (whiter) appearance laterally ^[3]
Homogeneous opacity without air bronchograms	Distinguishes effusion from consolidation (which HAS air bronchograms) ^[4]
Mediastinal shift away from the opacity	Large effusion acts as space-occupying lesion. If shift is toward the opacity → suspect associated collapse (e.g., bronchial obstruction by tumour)
Amount estimation: CP angle blunted ≈ 175 mL; lower 1/3 ≈ 1 L; lower 1/2 ≈ 2 L ^[1]	Quick bedside estimate of volume
> 1 cm thick on lateral decubitus film → suitable for pleural tapping ^[1]	Clinical decision point for thoracocentesis
Air-fluid level (flat, horizontal)	Hydropneumothorax — fluid + air coexist ^[3]

Additional features to examine on CXR (looking for the CAUSE) ^[4]:

Lung fields: masses, consolidation, cavitation → malignancy, pneumonia, TB
Hilum: hilar enlargement → lymphoma, lung cancer, sarcoidosis
Heart: cardiomegaly → CHF
Bones: lytic lesions → metastatic disease
Upper lobe venous diversion + Kerley B lines → pulmonary venous congestion (CHF) ^[6]

CXR Quality Check — Don't Forget!

Before interpreting any CXR ^[5]:

Name, date, L/R label (dextrocardia?)
Inspiration adequacy: count 10 posterior ribs or 6 anterior ribs above the diaphragm
Rotation: medial ends of clavicles equidistant from spinous process
Penetration: retrocardiac window and T-spine outline just visible

An underexposed film may create a false "white-out" mimicking effusion.

More sensitive than CXR — can detect as little as ~20 mL of fluid. Increasingly used as the first-line bedside tool.

Feature	Interpretation
Transudate: clear hypoechoic space (black, no internal echoes) ^[2]^[3]	Simple fluid, no debris
Exudate: moving floating densities or septations ^[2]^[3]	Internal echoes = protein/cellular debris. Septations suggest loculation (fibrin strands dividing the fluid into compartments)
Differentiate from pleural thickening	Fluid: anechoic/hypoechoic, flows with respiration, compressible. Thickening: echogenic, fixed, non-compressible ^[1]
Echogenicity	Echogenic fluid → suggests exudative ^[1]. But note: anechoic fluid can be either transudative or exudative
Loculations	Multiple septated collections that don't communicate — indicates complicated parapneumonic/empyema or chronic effusion ^[1]
Guide drainage and biopsy	USG-guided thoracocentesis has significantly lower pneumothorax rates compared with blind aspiration (~0.5% vs ~5-15%) ^[1]
Volume estimation	USG can quantify effusion volume more accurately than CXR

Reserved for complex or uncertain cases. Provides the most comprehensive anatomical information.

Indication	What It Shows
Uncertain diagnosis after initial CXR + tap ^[1]	Precise effusion location, size, and relationship to adjacent structures
Suspected malignancy	Pleural thickening, nodularity (lobulated contour → malignancy) ^[4], masses, mediastinal lymphadenopathy, bony metastases
Empyema characterisation	Pleural thickening with contrast enhancement (the "split pleura sign" — enhancing visceral and parietal pleura separated by infected fluid) ^[1]^[4]
Parapneumonic effusion	Pleural thickening with contrast enhancement on CT thorax — one of the indications for chest drain ^[1]
Guide biopsy	Image-guided TEMNO needle biopsy of focal pleural lesions
r/o PE	CTPA (CT pulmonary angiography) if PE suspected as the cause

Radiological approach to pleural shadows on CT ^[4]:

Colour/density: effusion = darker than chest wall muscle; thickening = same density; plaques = very bright white
Contour: smooth → fluid, thickening, or plaques; lobulated → malignancy
Distribution: diffuse → benign thickening or malignant pleural disease; patchy → pleural plaques
Enhancement: enhanced → empyema

Indication	Rationale
Malignancy suspected or initial tap non-diagnostic ^[2]^[3]	PET detects metabolically active (FDG-avid) pleural deposits, helps differentiate malignant from benign pleural thickening, and stages distant disease
Mesothelioma staging	Determines resectability and distant metastasis

These are not diagnostic of pleural effusion itself but help identify the underlying cause and prepare for procedures ^[1]^[6]:

Test	Purpose	Key Findings
CBC	Infection (↑WBC), anaemia, thrombocytopenia	↑WBC with left shift → pneumonia/empyema. ↓Hb → chronic disease (malignancy, TB)
Clotting profile	Prep for pleural tapping ^[1]	Must check before any invasive pleural procedure to minimise bleeding risk
CRP / ESR	Inflammation ^[1]	↑ in infection, TB, malignancy, autoimmune. Useful for monitoring treatment response
LRFT (liver + renal function tests)	Assess hepatic/renal causes ^[1]	↓albumin (cirrhosis, nephrotic), ↑creatinine (renal failure), ↑ALP/GGT (liver mets)
Serum LDH	Paired with pleural fluid LDH for Light's criteria ^[1]	Essential — you cannot interpret Light's criteria without simultaneous serum LDH
Serum protein + albumin	Paired for Light's criteria + albumin gradient	Essential
BNP / NT-proBNP	Distinguish cardiac from non-cardiac cause of dyspnoea	< 100 pg/mL → HF unlikely. > 400 pg/mL → HF likely. Can also be measured in pleural fluid (pleural fluid BNP > 1500 pg/mL → CHF) ^[6]
D-dimer	Screening for PE in low pre-test probability	Sensitive but not specific. Negative D-dimer in low-risk patient effectively rules out PE
Autoimmune markers (ANA, anti-dsDNA, RF, anti-CCP, complement C3/C4)	If CTD suspected	+ve ANA + anti-dsDNA → SLE. +ve RF + anti-CCP → RA
TSH	If myxoedema suspected	↑TSH → hypothyroidism

Pleural biopsy is indicated for exudative effusion with non-diagnostic thoracocentesis, especially for TB and malignancy ^[3].

Method	Technique	Best For	Advantages	Limitations
Bedside percutaneous (Abram's needle)	Blind biopsy of parietal pleura at bedside	TB (first-line in HK because TB pleuritis is common) ^[1]^[3]	Cheap, quick, no GA, good for TB (granulomas are diffuse on pleura → high yield with blind biopsy)	Poor sensitivity for malignant pleural effusion (tumour deposits are focal → blind biopsy may miss them) ^[1]
Imaging-guided (TEMNO needle)	USG- or CT-guided targeted biopsy	Focal pleural thickening or nodularity (malignancy) ^[1]	Targets specific lesions → ↑sensitivity for malignancy. In TB-endemic regions (including HK), used as alternative to blind biopsy ^[3]	Requires radiology support
Medical thoracoscopy / pleuroscopy	Semi-rigid scope inserted through small chest wall incision under IV sedation (not GA) ^[1]	Both TB and malignancy. Also allows therapeutic intervention	Allows direct visualisation + biopsy + drainage + pleurodesis in one procedure ^[1]. Sensitivity for malignancy > 90%	Semi-invasive, requires trained operator
VATS (video-assisted thoracoscopic surgery)	Rigid thoracoscope under general anaesthesia with single-lung ventilation	Complex cases needing surgical intervention (e.g., decortication, trapped lung) ^[1]	Most definitive diagnostic + therapeutic. Can perform decortication simultaneously	Requires GA, operating theatre, and cardiothoracic surgeon

Abram's Needle vs Medical Thoracoscopy — When to Use Which?

In Hong Kong, where TB is common, Abram's needle biopsy is first-line because TB granulomas are diffusely distributed on the parietal pleura — even a blind biopsy has a good chance of hitting granulomatous tissue (sensitivity ~80% for TB). However, for suspected malignancy, where tumour deposits may be focal and patchy, blind biopsy has poor sensitivity (~50%). In this case, medical thoracoscopy is preferred as it allows direct visualisation of the pleural surface to target suspicious areas for biopsy ^[1]^[3].

H. Special Diagnostic Scenarios

Modality	Sensitivity for Effusion	Key Role	Limitations
CXR (PA erect)	≥ 175 mL	First-line screening; assess volume; identify cause (mass, cardiomegaly, consolidation)	Misses small effusions; poor for characterisation
CXR (lateral decubitus)	≥ 100 mL	Confirm free-flowing; detect loculation; assess tappability (> 1 cm)	Additional film needed
USG thorax	≥ 20 mL	Most sensitive bedside tool; characterise fluid; guide procedures; detect loculation	Operator-dependent
CT thorax ± contrast	Very high	Complex/uncertain cases; malignancy staging; empyema characterisation; guide biopsy	Radiation; cost; contrast risks
PET-CT	N/A	Differentiate malignant vs benign pleural disease; staging	Cost; availability; false positives in inflammation
Thoracocentesis	N/A	Light's criteria; extended fluid analysis; determine aetiology	Complications (PTX, bleeding, re-expansion oedema)
Pleural biopsy (blind)	~80% for TB	First-line for TB in endemic areas (HK)	Poor for malignancy (~50%)
Medical thoracoscopy	> 90% for malignancy	Biopsy + drainage + pleurodesis in one procedure	Semi-invasive; requires trained operator
VATS	Highest	Definitive diagnostic + therapeutic (decortication)	Requires GA + single-lung ventilation

High Yield Summary — Diagnosis

Light's Criteria (MUST KNOW): Exudate if ANY ONE of: pleural/serum protein > 0.5, pleural/serum LDH > 0.6, pleural LDH > 2/3 ULN serum LDH. Always send paired serum sample.

Albumin gradient correction: Serum Alb − Pleural Alb > 12 g/L → transudate (use when Light's misclassifies in diuretic patients).

When NOT to tap: Bilateral + clearly transudative + responds to treatment.

Extended fluid analysis for exudate: pH, glucose, ADA, amylase, TG, cell count/diff, Gram/AFB/culture, cytology (20 mL × 3).

Chest drain indications from fluid: frankly purulent, pH < 7.2, glucose < 2.2, +ve Gram stain.

ADA > 30–40 in lymphocytic effusion → TB (especially in HK). Abram's needle biopsy is first-line for TB.

Cytology negative × 2–3 with malignancy suspected → CT thorax → medical thoracoscopy (sensitivity > 90%).

Imaging hierarchy: CXR → USG → CT ± PET-CT. USG most sensitive bedside; CT for complex cases.

Hepatic hydrothorax: Do NOT insert chest tube. Treat with diuretics, Na restriction, ± TIPS.

CXR volume estimation: CP angle blunted ≈ 175 mL; lower 1/3 ≈ 1 L; lower 1/2 ≈ 2 L. Decubitus > 1 cm → tappable.

Active Recall - Diagnostic Criteria, Algorithm, and Investigations for Pleural Effusion

References

Management of Pleural Effusion

B.1 Treat the Underlying Cause — Always First [2][3]

This cannot be overemphasised. The most elegant chest drain insertion means nothing if you haven't addressed why the fluid is there in the first place.

Cause	Specific Treatment	Mechanism of Benefit
CHF	Diuretics (e.g., furosemide) ^[1], ACE inhibitors/ARBs, fluid and sodium restriction, optimise cardiac medications	↓intravascular volume → ↓hydrostatic pressure → fluid reabsorbed from pleural space back into the capillaries
Hepatic cirrhosis / Hepatic hydrothorax	Diuretics, Na restriction, ± thoracocentesis or TIPS ^[7]. Do NOT put in chest tube → may cause massive protein/electrolyte depletion, infection, renal failure, bleeding ^[7]	Diuretics reduce ascites volume → ↓pressure driving fluid through diaphragmatic defects. TIPS ↓portal pressure → ↓ascites formation
Nephrotic syndrome	Treat underlying glomerulonephritis, diuretics, IV albumin (temporising)	Treat proteinuria → ↑serum albumin → ↑oncotic pressure → fluid reabsorption
Renal failure	Dialysis, fluid restriction	Remove excess fluid directly
TB pleuritis	Standard anti-TB chemotherapy (RIPE regimen, 6–9 months)	Kill M. tuberculosis → resolve granulomatous inflammation → effusion resolves. Most TB effusions resolve with treatment alone without drainage
PE	Anticoagulation (heparin → warfarin/DOAC)	Prevent clot propagation → allow natural fibrinolysis → ↓pulmonary vascular obstruction → ↓effusion
Autoimmune (SLE, RA)	DMARDs, corticosteroids, biological agents	Suppress immune-mediated pleural inflammation
Pancreatitis	Treat pancreatitis (NPO, fluids, analgesia); effusion usually resolves as pancreatitis resolves	Reduce pancreatic enzyme leak into pleural space

Bilateral pleural effusion: treat underlying cause (e.g., furosemide) → chest drain if failed or respiratory distress ^[1].

Unilateral pleural effusion: chest drain ^[1] (after determining the cause — this is a simplified statement; not every unilateral effusion needs a drain).

Hepatic Hydrothorax — The Chest Tube Trap

This is a classic exam pitfall: Do NOT insert a chest tube for hepatic hydrothorax ^[7]. Why? Because the diaphragmatic defect creates a one-way valve — ascitic fluid will continuously flow into the pleural space through the defect, driven by positive intra-abdominal pressure. The chest tube will drain indefinitely, leading to: (1) massive protein loss → worsening hypoalbuminaemia, (2) electrolyte depletion, (3) infection risk from indwelling tube, (4) renal failure from volume depletion. Instead, manage medically with diuretics, sodium restriction, and consider TIPS for refractory cases.

C. Therapeutic Thoracocentesis (Therapeutic Tap)

Complication	Incidence	Mechanism	Prevention
Pneumothorax	2–15%	Inadvertent puncture of visceral pleura by needle; or air entry through 3-way tap connections	USG guidance; ensure proper sealing of all tap joints
Procedure failure	Variable	Loculated fluid; incorrect site	USG guidance; lateral decubitus film pre-procedure
Bleeding (haemothorax, haemoptysis)	Rare	Laceration of intercostal artery or lung parenchyma	Insert above the rib (NVB runs below); check clotting profile pre-procedure
Pain	Common	Pleural nerve stimulation	Adequate local anaesthesia
Visceral damage (liver and spleen)	Rare	Puncture below the diaphragm	Correct site selection (not below 8th rib posteriorly); USG guidance
Re-expansion pulmonary oedema (RPO)	0–1% ^[8]	Rapid re-expansion → restoration of blood flow into compressed capillaries → capillary damage with leakage ^[8]	Avoid draining > 1–1.5 L in one session; drain slowly
Pleural infection/empyema	Rare	Iatrogenic bacterial introduction	Strict aseptic technique
Vagal shock	Rare	Vasovagal response to pleural stimulation	Pre-procedure anxiolysis; have atropine available
Air embolism	Very rare	Air enters pulmonary vein via injured lung	Proper technique
Seeding of mesothelioma	Rare but important	Mesothelioma cells track along the needle/biopsy tract	Should AVOID biopsy if mesothelioma is suspected (through traditional routes — thoracoscopy preferred) ^[3]

Why does re-expansion pulmonary oedema (RPO) occur? ^[8] When a lung has been compressed for a prolonged period ( > 3 days), the pulmonary capillary endothelium is damaged by ischaemia and oxidative stress. When the lung suddenly re-expands, blood flow returns to these damaged capillaries → protein-rich fluid leaks into the alveoli → unilateral pulmonary oedema. Risk factors include lung collapse > 3 days, high-volume drainage, and early suction use ^[8]. Signs: cough, SOB, desaturation that improves upon clamping the drain. CXR: alveolar shadowing. Management: supportive + clamp drain ^[8].

D. Chest Tube (Thoracostomy) Drainage

Chest tube drainage is a more definitive drainage modality than simple thoracocentesis. The key question is: when do you escalate from a simple tap to a chest drain?

Chest drain (large-bore) is indicated if ^[1]:

Clinical indications:

Respiratory distress ^[1]
Sepsis ^[1]

Radiological indications:

Large non-purulent effusion (≥ 40% of hemithorax) ^[1]
Loculation on CXR/USG ^[1]
Pleural thickening with contrast enhancement on CT thorax ^[1]

Pleural fluid indications (complicated effusion or empyema):

Appearance: overtly purulent (empyema) ^[1]
Biochemical: pH < 7.2 or glucose < 2.2 mmol/L ^[1]
Microbiology: positive Gram stain ± culture ^[1]

Tube Size	Indication
24 Fr	Air (pneumothorax) ^[9]
28–32 Fr	Blood or pus (haemothorax, empyema) ^[9]
Small-bore (10–14 Fr)	May be used for simple drainage; may be more prone to blockage and may need periodic flushing, but trials did not show difference in outcome between large vs small-bore tubes ^[2]

E. Management of Parapneumonic Effusion and Empyema (SAQ!) [1][2]

This is one of the most commonly tested management algorithms in the exam. The approach is escalating:

When chest drain drainage is inadequate (persistent sepsis, loculated collections not draining, trapped lung), escalate in this order:

Step	Modality	Mechanism	Details
1st	Intrapleural tPA + DNase	tPA (tissue plasminogen activator) dissolves fibrin clots and DNase (deoxyribonuclease) breaks down extracellular DNA from neutrophil NETs (neutrophil extracellular traps) → together they dissolve loculations and reduce fluid viscosity, allowing drainage through the existing chest tube ^[1]^[2]	Instilled through the chest drain; the MIST2 trial showed this combination ↓surgical referral and ↓hospital stay compared to either agent alone
2nd	VATS for surgical drainage and decortication	Peel away thickened pleura (fibrous "peel") → allow lung re-expansion ^[1]	Decortication = removal of the organized fibrous cortex that encases and traps the lung. VATS approach preferred (↓morbidity vs open thoracotomy)
3rd	Thoracoplasty	Airspace-filling procedures with surgical flap (e.g., latissimus dorsi flap) ^[1]	Collapses the chest wall to obliterate the empyema space when the lung cannot re-expand
4th	Open drainage of empyema (Clagett's procedure) ^[1]	Open thoracostomy window → allows chronic drainage and gradual obliteration of the empyema space	Reserved for chronically ill patients unfit for major surgery

tPA + DNase — Why Both?

In empyema, the pleural space contains a thick, viscous soup of fibrin (from the coagulation cascade activated by inflammation), pus (dead neutrophils), and DNA (released from dead neutrophils and bacteria via NETosis). tPA alone breaks down fibrin but does nothing to the DNA-rich "goo." DNase alone breaks down DNA but leaves the fibrin matrix intact. Together, they synergistically liquify the entire mess, allowing it to drain through the chest tube. Think of it like needing both a protein-dissolving enzyme and a DNA-dissolving enzyme to clear two different types of obstruction ^[1]^[2].

F. Management of Malignant Pleural Effusion (MPE) [1][2][3][10]

MPE indicates advanced disease, usually incurable. The goal of management is symptom palliation and quality of life, not cure.

Step	Modality	Indication	Details
Initial	Treat the underlying malignancy	If responsive to systemic therapy (e.g., certain lymphomas, breast cancer, SCLC)	Chemotherapy/targeted therapy/immunotherapy may control the effusion by shrinking tumour burden
1st	Repeated therapeutic thoracocentesis every few weeks ^[1]^[10]	Slowly accumulating effusions; patients with limited life expectancy	Simple, low-risk, provides symptomatic relief. Avoid draining > 1–1.5 L per session
2nd	Consult respiratory team if persistent/recurrent ^[10]	When effusion re-accumulates rapidly → repeated taps become impractical	—
3rd (expandable lung)	Chemical pleurodesis (1st line for recurrent MPE) ^[10]	Pre-requisite: lung must be fully expanded to allow pleural apposition ^[2]	See pleurodesis section below
3rd (expandable lung, good PS)	Surgical pleurodesis: can be considered if good performance status ^[10]	Better pleurodesis rates than chemical alone in fit patients	Via VATS
3rd (non-expandable / trapped lung, or short life expectancy)	Long-term ambulatory indwelling pleural catheter (IPC) ^[10]	Consider if short life expectancy / trapped lung ^[10]	See IPC section below
Alternative	Pleuroperitoneal shunt (e.g., Denver shunt) ^[10]	Consider if short life expectancy / trapped lung ^[10]	Shunts pleural fluid into the peritoneal cavity; rarely used; requires manual pumping

PleurX drain: long-term drainage for recurrent pleural effusion ^[11] — this is the brand name commonly used in Hong Kong for the IPC.

G. Pleurodesis — Detailed Management

Pleurodesis (from Greek pleura = side/rib + desis = binding) is a procedure to permanently obliterate the pleural space by inducing adhesion between the visceral and parietal pleurae ^[2]^[3]^[10].

Preferred in recurrent MPE or surgically unfit patients ^[10].

Principle: Irritation to stimulate chronic inflammation → adhesion and fibrosis formation → obliteration of pleural space ^[3]

Agents ^[2]^[10]:

Agent	Details
Talc (5 g in 100 mL NS) — i.e., magnesium silicate	Most commonly used and most effective agent. Can be administered as slurry via chest drain or poudrage (direct application) via thoracoscope. Success rate ~80–90%
Minocycline (300 mg in 100 mL NS)	Alternative tetracycline; more data for pneumothorax than for MPE
Autologous blood	Lower risk of cardiac arrest ^[10]; used when talc is unavailable or contraindicated
Bleomycin	Associated with systemic toxicity ^[2]; rarely used now

Procedure ^[10]:

Adequate analgesia ± sedation — pleurodesis causes significant pleuritic pain (the inflammation is intentional)
Connect chest drain, then apply sclerosing agent via drain when lung re-expanded
Clamp chest drain for 1–2 hours to hold the sclerosant in contact with the pleural surfaces
If co-existing pneumothorax / bubbling chest drain → do NOT clamp drain → instead hang up drain to ~50 cm above patient to drain air but retain the sclerosant ^[10]
Continue drainage until drain output < 150 mL/day × 2 days + CXR shows lung re-expanded ^[10]

Complications ^[10]:

Pain (most common) — avoid NSAIDs because the inflammatory action of pleurodesis is essential for success ^[10]. Use opioids or paracetamol instead
Fever — expected inflammatory response
Recurrence — 3% with surgical pleurodesis ^[10]; higher with chemical pleurodesis (~10–20%)
Rare: cardiac arrhythmia, respiratory failure (especially with talc poudrage using non-graded talc → can cause ARDS)

Why Avoid NSAIDs After Pleurodesis?

This is counterintuitive — the patient is in pain, and NSAIDs are excellent analgesics. But the entire mechanism of pleurodesis depends on inducing inflammation. The sclerosant (talc, minocycline, etc.) irritates the pleural mesothelial cells → triggers an inflammatory cascade with fibrin deposition → fibrosis → permanent adhesion. NSAIDs block cyclooxygenase (COX) → ↓prostaglandin synthesis → ↓inflammation → pleurodesis failure. Use opioids or paracetamol for post-pleurodesis pain instead ^[10].

H. Indwelling Pleural Catheter (IPC) [2][3][10][11]

I. Management of Specific Subtypes

Step	Management	Rationale
Conservative (first-line)	NPO or low-fat diet with medium-chain triglycerides (MCTs); TPN if NPO	MCTs are absorbed directly into the portal venous system (not via lacteals/thoracic duct) → ↓chyle production → ↓flow through damaged thoracic duct → allows healing
Chest drainage	If symptomatic or large	Relieve respiratory compromise
Octreotide	↓splanchnic blood flow → ↓lymph production	Adjunctive medical therapy
Surgical ligation or embolisation of thoracic duct	If conservative treatment fails after 1–2 weeks	Definitive: ligate or embolise the thoracic duct proximal to the leak site
Pleurodesis	Chylothorax with failed conservative treatment ^[10]	Obliterate the pleural space to prevent re-accumulation

Step	Management	Rationale
Chest drain (large-bore, 28–32 Fr) ^[9]	First-line: drainage + monitoring of output	Large bore needed because blood clots can occlude small-bore tubes
Surgical exploration (thoracotomy/VATS)	If drain output > 1500 mL immediately, or > 200 mL/hour for 2–4 hours, or haemodynamically unstable	Indicates major vascular injury requiring surgical haemostasis
Blood transfusion + resuscitation	If significant blood loss	Replace intravascular volume and oxygen-carrying capacity

Procedure	Key Complications
Therapeutic thoracocentesis	Pneumothorax (2–15%), bleeding, RPO, infection, visceral damage, vagal shock
Chest tube drainage	Same as above, plus tube malposition, subcutaneous emphysema, empyema, tube blockage
Chemical pleurodesis	Pain (avoid NSAIDs), fever, recurrence (~10–20%), cardiac arrhythmia, ARDS (non-graded talc)
Surgical pleurodesis	Pain, recurrence (~3%), surgical complications (bleeding, infection, prolonged air leak)
IPC	Infection, blockage, tract metastasis, protein/electrolyte loss
VATS decortication	Bleeding, prolonged air leak, empyema, intercostal neuralgia

High Yield Summary — Management of Pleural Effusion

Principle: Treat the underlying cause FIRST. Drainage is adjunctive.

Transudative: Treat the systemic cause (diuretics for CHF; Na restriction + diuretics for cirrhosis; treat GN for nephrotic). Tap only if symptomatic or refractory.

Hepatic hydrothorax: Do NOT insert chest tube → causes massive protein/electrolyte depletion, infection, renal failure. Use diuretics, Na restriction, ± TIPS.

Parapneumonic/Empyema (SAQ!):

Antibiotics: 1–2 weeks (uncomplicated) or 4–6 weeks (empyema)
Chest drain if: purulent, pH < 7.2, glucose < 2.2, +ve Gram stain, large (≥40% hemithorax), loculated, sepsis
If drain fails: intrapleural tPA + DNase → VATS decortication → thoracoplasty/Clagett
Pathogens: Strep milleri, Strep pneumoniae, S. aureus, anaerobes

Malignant pleural effusion:

Repeated thoracocentesis (initial)
Chemical pleurodesis (1st-line if recurrent, lung expandable): talc 5 g in 100 mL NS
Surgical pleurodesis via VATS (if good performance status)
IPC (if trapped lung / short life expectancy)
Pleuroperitoneal shunt (Denver shunt — rarely used)

Pleurodesis:

Indications: recurrent MPE, recurrent PTX (SSP; PSP recurrent/bilateral/PAL), failed conservative chylothorax
Contraindications: empyema (traps infection)
Prerequisite: lung must be fully expanded
Avoid NSAIDs post-pleurodesis (inhibits the necessary inflammation)
Chemical: talc, minocycline, autologous blood. Surgical: abrasion, pleurectomy, VATS

Therapeutic tap: Max 1–1.5 L per session to avoid RPO. RPO mechanism: rapid re-expansion → capillary damage → unilateral pulmonary oedema.

Chest tube sizes: 24 Fr for air; 28–32 Fr for blood/pus.

Active Recall - Management of Pleural Effusion

References

^[1] Senior notes: Maksim Medicine Notes.pdf (Pleural effusion and parapneumonic effusion sections, p290-293) ^[2] Senior notes: Ryan Ho Respiratory.pdf (Section 2.4 Pleural Effusion management, p26-28; Parapneumonic effusion, p72) ^[3] Senior notes: Ryan Ho Fundamentals.pdf (Section 3.2.4 Pleural Effusion management, p229) ^[7] Senior notes: Ryan Ho GI.pdf (Hepatic hydrothorax management, p314) ^[8] Senior notes: Ryan Ho Respiratory.pdf (Re-expansion pulmonary oedema and pneumothorax management, p154-155) ^[9] Senior notes: Maksim Surgery Notes.pdf (Chest drainage tube, p12) ^[10] Senior notes: Maksim Medicine Notes.pdf (Malignant pleural effusion and pleurodesis, p294) ^[11] Senior notes: Ryan Ho Diagnostic Radiology.pdf (PleurX drain for recurrent pleural effusion, p89)

Complications of Pleural Effusion

Complications of pleural effusion can be organised into two broad categories: (A) complications arising from the effusion itself (the disease process), and (B) complications arising from interventions used to diagnose and treat the effusion (iatrogenic). Both are important for exams and for clinical practice — you need to understand the "why" behind each complication to anticipate, prevent, and manage it.

A. Complications of the Effusion Itself

These are consequences of the underlying disease process and the physical effects of fluid accumulating in the pleural space.

Complication	Pathophysiology	Clinical Significance
Progressive dyspnoea and hypoxia	Large effusion → compresses underlying lung parenchyma → ↓functional residual capacity → V/Q mismatch (perfusion to compressed, non-ventilated lung units) → hypoxaemia. Additionally, the effusion splints the ipsilateral hemidiaphragm and chest wall → ↓mechanical efficiency of breathing → ↑work of breathing ^[2]^[3]	The most common complication. Severity depends on effusion size, rate of accumulation, and the patient's underlying cardiopulmonary reserve. A young, fit patient may tolerate 1 L of fluid asymptomatically; an elderly COPD patient may become critically dyspnoeic with 500 mL
Atelectasis (compressive)	Fluid mass effect compresses adjacent lung → alveolar collapse → loss of lung volume	May persist even after drainage if the lung has been compressed for a prolonged period. Chest physiotherapy and mobilisation are essential post-drainage
Respiratory failure	Massive effusion (especially bilateral) → severe V/Q mismatch + mechanical restriction → Type 1 respiratory failure (↓PaO₂, N/↓PaCO₂). If respiratory muscles fatigue → may progress to Type 2 (↑PaCO₂)	Requires urgent therapeutic drainage ± supplemental oxygen ± mechanical ventilation in severe cases

This applies specifically to parapneumonic effusions and represents the natural progression of untreated pleural infection ^[1]^[2]:

Stage	What Happens	Why It Matters
Uncomplicated → Complicated	Bacteria cross the damaged visceral pleura into the sterile pleural space → intrapleural inflammation → fibrin deposition → loculations form (fibrin strands divide the fluid into non-communicating pockets). pH drops < 7.2, glucose drops < 2.2 mmol/L as bacteria and neutrophils consume glucose anaerobically ^[1]^[2]	A complicated parapneumonic effusion will NOT resolve with antibiotics alone — it requires chest tube drainage. If missed, it progresses to empyema
Complicated → Empyema	Continued bacterial proliferation + massive neutrophil influx → frank pus accumulates in the pleural space ^[1]^[2]	Empyema requires prolonged antibiotics (4–6 weeks ^[1]) and drainage. Mortality is significant (~15–20%)
Sepsis: pleural "peel" as reservoir for recurrent infections ^[1]	The organised fibrous peel that forms around chronic empyema can harbour bacteria (including TB), acting as a nidus for recurrent septic episodes even after antibiotics are completed	May require surgical decortication to remove the peel and eliminate the infective reservoir

This is one of the most important chronic complications:

Complication	Pathophysiology	Consequences
Trapped lung → reduced lung function ^[1]	Organized: Fibrinous pleural "peel" develops to encase lung ^[1]. Chronic pleural inflammation (from empyema, TB, haemothorax, or malignancy) → fibroblast proliferation → thick fibrous cortex ("peel") forms over the visceral pleura → physically restricts lung expansion	The lung becomes permanently unable to expand fully. This causes: (1) persistent restrictive lung disease, (2) chronic dyspnoea, (3) inability to perform pleurodesis (because the lung cannot appose the chest wall). CXR: pleural effusion replaced by air after thoracocentesis (ex vacuo pneumothorax) ^[2]
Fibrothorax	End-stage of organized empyema/haemothorax: the entire pleural space becomes obliterated by dense fibrous tissue. Both visceral and parietal pleurae are thickened and fused	Permanent loss of lung function on the affected side. May require decortication (surgical peeling of the fibrous cortex) if clinically significant. Usually resolves over 3–6 months but sometimes forms a true scar ^[2]

Distinction to understand ^[10]:

Lung entrapment: lung cannot expand fully because of an active disease (e.g., active malignancy encasing the lung); the pleural fluid is exudative

Trapped lung: lung cannot expand fully because of a remote inflammatory condition that left behind a fibrous peel; the pleural fluid is transudative (the inflammation is gone, but the scar remains)

These represent a continuum of the same disease process: the active disease resolves, leaving behind fibrosis ^[10]

Complication	Pathophysiology	Clinical Features
Rupture into bronchus → bronchopleural fistula + pyopneumothorax ^[2]	Empyema erodes through the visceral pleura into a bronchus → creates an abnormal communication between the pleural space and the bronchial tree	Sudden onset of: (1) cough productive of large volumes of purulent sputum (the empyema drains into the airway), (2) fever, (3) CXR shows new air-fluid level (pyopneumothorax = pus + air in the pleural space). This is a surgical emergency — risk of aspiration of pus into the contralateral lung

Underlying Cause	Specific Complication	Pathophysiology
Malignant pleural effusion	Cachexia, progressive respiratory failure, death	MPE indicates advanced, usually incurable disease. Median survival: ~4–6 months for lung cancer-related MPE
TB pleuritis	Residual pleural thickening, fibrothorax	Even after successful anti-TB treatment, the granulomatous inflammation can leave behind significant fibrosis → permanent restrictive lung disease
Hepatic hydrothorax	Spontaneous bacterial empyema (SBEM)	Analogous to SBP (spontaneous bacterial peritonitis) in ascites — infected ascitic fluid crosses the diaphragmatic defect into the pleural space → empyema without preceding pneumonia. Pathogens similar to SBP (E. coli, Klebsiella, Streptococcus). Must NOT be treated with chest tube drainage ^[7]
Chronic pancreatitis	Pancreatic ascites and pleural effusion due to disruption of pancreatic duct or ruptured pseudocyst with fistulation into peritoneal/pleural cavity ^[12]	Pancreatic duct disruption → enzyme-rich fluid tracks through the diaphragm → left-sided pleural effusion with very high amylase. Diagnosis: ↑↑amylase concentration in pleural or ascetic fluid. Management: octreotide (↓pancreatic secretion), endoscopic stents, surgical fistula correction if fail ^[12]
Chylothorax	Malnutrition, immunosuppression	Chronic loss of chyle (rich in proteins, lymphocytes, immunoglobulins, and fat-soluble vitamins) → progressive protein-calorie malnutrition + lymphopenia → immunosuppression

These are complications arising from the diagnostic and therapeutic interventions used to manage pleural effusion. Systematically categorised ^[1]^[3]^[10]:

These can occur during thoracocentesis, chest drain insertion, or pleural biopsy:

Complication	Incidence	Pathophysiology	Prevention & Management
Pneumothorax	2–15% ^[3]	Needle punctures the visceral pleura → air leaks from the lung into the pleural space. Alternatively, air enters through the puncture site if the system is not properly sealed	Prevention: USG guidance (↓rate to ~0.5%); ensure all 3-way tap connections are sealed. Management: Small pneumothorax → observe + supplemental O₂. Large or symptomatic → chest drain
Haemothorax / haemoptysis	Rare	Laceration of intercostal artery (runs along the inferior border of each rib) or lung parenchyma → bleeding into pleural space or airway	Prevention: Insert needle/drain immediately above the rib (not below). Check clotting profile pre-procedure. Management: Chest drain for haemothorax; surgical consultation if massive
Surgical emphysema (subcutaneous emphysema)	Uncommon	Air tracks from the pleural space along the chest drain tract into the subcutaneous tissue	Management: Look for and treat underlying cause (e.g., tube obstruction); high-concentration O₂; infraclavicular incisions if severe and progressive ^[10]
Organ perforation (visceral damage: liver, spleen) ^[3]	Rare	Needle inserted too low (below the diaphragm) → punctures the liver (right side) or spleen (left side)	Prevention: Do not insert below the 8th rib posteriorly. USG guidance to confirm diaphragm position
Damage to neurovascular bundle	Rare	Needle inserted below the rib margin → lacerates the intercostal nerve, artery, or vein	Prevention: Insert immediately above the rib
Bronchopleural fistula (iatrogenic) ^[10]	Rare	Needle or drain damages the visceral pleura and lung parenchyma → persistent air leak from lung into pleural space	Management: Continue chest drain with low wall suction; CT thorax to localise the leak → consider endobronchial valve (EBV) or pleurodesis. NEVER clamp the drain (risk of tension pneumothorax) ^[10]
Segmentation	Uncommon	Pockets formed by scar tissue after each puncture ^[10] → repeated thoracocentesis causes fibrotic adhesions that divide the pleural space into separate loculated compartments	Makes subsequent drainage more difficult. May require image-guided drainage or VATS

Complication	Pathophysiology	Prevention & Management
Re-expansion pulmonary oedema (RPO)	In pleural effusion: avoid draining > 1.5 L in 30 minutes ^[10]. When a chronically compressed lung re-expands rapidly, blood flow returns to ischaemia-damaged capillaries → endothelial leakage → unilateral pulmonary oedema. Risk factors: lung collapse > 3 days, high-volume drainage, early suction use ^[8]	Prevention: Drain slowly; limit to 1–1.5 L per session; stop if patient develops cough, chest tightness, or desaturation. Management: Clamp drain immediately; supportive care (oxygen, diuretics for oedema); usually self-limiting
Blockage ^[10]	Blood clots, fibrin, or debris occlude the drain lumen → drainage stops	Prevention: Regular flushing (especially small-bore tubes). Management: Flush with 20–30 mL sterile saline; if unsuccessful → replace drain
Dislodgement ^[10]	Inadequate fixation → drain falls out or migrates	Prevention: Secure with suture and adhesive dressing; mark insertion depth on the drain. Management: Replace if still indicated
Infection (empyema) ^[3]^[10]	Bacteria introduced during insertion or via the drain tract over time	Prevention: Strict aseptic technique; minimise drain duration. Management: Antibiotics; may need drain repositioning or replacement

Complication	Pathophysiology	Key Points
Pain	Sclerosant irritates the parietal pleura (which has somatic innervation) → intense pleuritic pain. This is the intended inflammatory response but causes significant patient discomfort	Avoid NSAIDs (would inhibit the inflammation needed for pleurodesis success). Use opioids or paracetamol ^[10]
Fever	Expected inflammatory response to sclerosant → cytokine release (IL-1, IL-6, TNF-α) → systemic febrile response	Self-limiting; monitor for true infection but do not reflexively treat with antibiotics
Recurrence	Incomplete adhesion between pleural surfaces → fluid re-accumulates. Recurrence: ~3% with surgical pleurodesis; ~10–20% with chemical pleurodesis ^[10]	Risk factors: trapped lung (inability to appose pleura), inadequate drainage before pleurodesis, low pH effusion (malignant effusion with low pH has lower pleurodesis success rate ^[2])
ARDS (with talc)	Non-graded talc (containing small particles < 15 μm) can be systemically absorbed → triggers systemic inflammatory response → diffuse alveolar damage. Graded/large-particle talc (≥ 15 μm) has much lower risk	Use graded, large-particle talc. Monitor closely after talc pleurodesis
Cardiac arrhythmia	Vagal stimulation or direct cardiac irritation from sclerosant (especially with autologous blood or when fluid is injected rapidly)	Monitor ECG during and after procedure

Complication	Pathophysiology
Infection (most feared)	Chronic indwelling foreign body → biofilm formation → ascending infection → empyema, cellulitis at insertion site
Blockage	Fibrin/protein clots occlude the catheter lumen
Tract metastasis	Tumour cells from the malignant effusion seed along the catheter insertion tract into the subcutaneous tissue and skin → cutaneous tumour nodules ^[2]
Protein and electrolyte depletion	Chronic drainage of protein-rich exudative fluid → progressive hypoalbuminaemia, hypokalaemia, hyponatraemia

Aetiology	Key Complications to Remember
Parapneumonic/Empyema	Sepsis (peel as reservoir); trapped lung → ↓lung function; BPF + pyopneumothorax; fibrothorax ^[1]^[2]
TB pleuritis	Residual pleural thickening/fibrothorax; calcification; rarely constrictive pleuritis
Malignant PE	Rapid re-accumulation; trapped lung/non-expandable lung; cachexia; death
Hepatic hydrothorax	Spontaneous bacterial empyema (SBEM); protein depletion if drained via chest tube; hepatorenal syndrome if over-drained ^[7]
Chylothorax	Malnutrition (protein + fat-soluble vitamin loss); lymphopenia → immunosuppression
Haemothorax	Hypovolaemic shock (spleen is extremely vascular); retained haemothorax → empyema; fibrothorax
Peritoneal dialysis	Peritoneal leakage: sites include pleural cavity (superior) → pleural effusion ^[13]. PD failure from peritoneal fibrosis

Intervention	Complications
Thoracocentesis	Pneumothorax (2–15%), procedure failure, bleeding (haemothorax/haemoptysis), pain, visceral damage (liver/spleen), RPO, pleural infection/empyema, vagal shock, air embolism, seeding of mesothelioma ^[3]
Chest tube drainage	All of the above + blockage, dislodgement, subcutaneous emphysema, bronchopleural fistula, segmentation ^[10]
Chemical pleurodesis	Pain (avoid NSAIDs), recurrence (~10–20%), fever, cardiac arrhythmia, ARDS (non-graded talc) ^[10]
Surgical pleurodesis	Pain, recurrence (~3%), bleeding, infection, prolonged air leak ^[10]
IPC	Infection, blockage, tract metastasis, protein/electrolyte depletion ^[2]
Pleural biopsy	Pneumothorax, bleeding, pain, tract seeding (especially mesothelioma)

High Yield Summary — Complications of Pleural Effusion

Disease-related complications:

Respiratory compromise (dyspnoea, hypoxia, atelectasis, respiratory failure) — from compression of lung
Progression to empyema (parapneumonic effusion → complicated → empyema → organized/trapped lung)
Trapped lung / fibrothorax — fibrous peel encases lung → permanent restrictive deficit. Distinction: lung entrapment (active disease, exudative fluid) vs trapped lung (remote inflammation, transudative fluid)
Bronchopleural fistula — empyema ruptures into bronchus → pyopneumothorax (surgical emergency)
Sepsis — fibrous peel acts as reservoir for recurrent infections (including TB)
Spontaneous bacterial empyema in hepatic hydrothorax (analogous to SBP)
Chylothorax → malnutrition + immunosuppression from chronic loss of chyle

Procedure-related complications:

Puncture: pneumothorax (2–15%), haemothorax, visceral damage, neurovascular bundle injury, surgical emphysema, segmentation from repeated punctures
Drain: RPO (avoid > 1.5 L in 30 min), blockage, dislodgement, infection, BPF (NEVER clamp drain if air leak — risk of tension pneumothorax)
Pleurodesis: pain (avoid NSAIDs — inflammatory action essential), fever, recurrence (3% surgical, 10–20% chemical), ARDS with non-graded talc
IPC: infection, blockage, tract metastasis, protein loss

Key management pearls for complications:

RPO: clamp drain + supportive; prevent by draining ≤ 1–1.5 L per session
Surgical emphysema: treat underlying cause + high-flow O₂ + infraclavicular incisions if severe
BPF: continue drain with low suction; CT to localise; EBV or pleurodesis; NEVER clamp
Hepatic hydrothorax: NEVER chest tube → protein depletion, renal failure, bleeding

Active Recall - Complications of Pleural Effusion

References

^[1] Senior notes: Maksim Medicine Notes.pdf (Parapneumonic effusion, empyema complications, p291-293) ^[2] Senior notes: Ryan Ho Respiratory.pdf (Parapneumonic effusion and empyema complications, p72; Non-expandable lung, p28; IPC complications, p28) ^[3] Senior notes: Ryan Ho Fundamentals.pdf (Therapeutic thoracocentesis complications, p229) ^[7] Senior notes: Ryan Ho GI.pdf (Hepatic hydrothorax complications, p314) ^[8] Senior notes: Ryan Ho Respiratory.pdf (Re-expansion pulmonary oedema, p154) ^[10] Senior notes: Maksim Medicine Notes.pdf (Pleurodesis complications, p294; Chest drain complications, p296) ^[12] Senior notes: Ryan Ho GI.pdf (Chronic pancreatitis complications — pancreatic pleural effusion, p350) ^[13] Senior notes: Ryan Ho Urogenital.pdf (PD complications — peritoneal leakage causing pleural effusion, p115)

Pleural Effusion

1. Definition

2. Epidemiology

Global Burden

Hong Kong Context

Risk Factors

3. Anatomy and Physiology of the Pleura

3.1 Pleural Anatomy

3.2 Pleural Fluid Dynamics (Starling Forces)

4. Etiology and Pathophysiology

4.1 Transudative vs. Exudative Framework

4.2 Transudative Causes (with Pathophysiology)

A. Increased Hydrostatic Pressure

B. Decreased Oncotic Pressure (Hypoalbuminaemia)

C. Other Transudative Causes

4.3 Exudative Causes (with Pathophysiology)

A. Increased Capillary Permeability (Pleural Inflammation)

B. Decreased Lymphatic Drainage

C. Traumatic / Iatrogenic

5. Classification

5.1 By Mechanism (Light's Criteria)

5.2 By Laterality

5.3 By Pleural Fluid Appearance

5.4 Parapneumonic Effusion Staging [1]

6. Clinical Features

6.1 Symptoms

6.2 Signs

6.3 Signs of Underlying Cause (Targeted Examination)

7. Relevant Imaging Features (Pre-Diagnosis Section)

7.1 Chest X-Ray [1][5]

7.2 Ultrasound (USG) Thorax [1]

7.3 CT Thorax with Contrast [1]

8. Pleural Fluid Analysis Overview

8.1 When to Tap

8.2 What to Send

8.3 Pleural Biopsy [1]

9. Special Pleural Effusion Subtypes (Focused Clinical Context)

9.1 Malignant Pleural Effusion (MPE)

9.2 TB Pleuritis

9.3 Hepatic Hydrothorax

9.4 Chylothorax

Active Recall - Pleural Effusion (Definition, Epidemiology, Etiology, Clinical Features)

References

Overview: The Clinical Problem

A. Differential Diagnosis by Transudative vs. Exudative Category

Transudative Effusion — "The Problem is Systemic"

Exudative Effusion — "The Problem is Local"

Infectious Causes

Malignant Causes

Inflammatory / Autoimmune Causes

Vascular / Traumatic Causes

Iatrogenic / Other

B. Differential Diagnosis Guided by Pleural Fluid Findings

By Biochemistry

By Cell Count and Differential

C. Differential Diagnosis of Radiological Mimics

D. Clinical Approach to Differential Diagnosis — Algorithm

E. Key Differentiating Features — Quick Reference Table

F. Uncommon but Must-Know Differentials

Active Recall - Differential Diagnosis of Pleural Effusion

A. The Fundamental Diagnostic Question

B. Light's Criteria — The Cornerstone Diagnostic Tool

B.1 The Criteria

B.2 Why These Three Parameters?

B.3 The Diuretic Pitfall — Albumin Gradient Correction

C. Extended Pleural Fluid Analysis — The Diagnostic Toolkit

C.1 Macroscopic Appearance

C.2 Biochemistry — Beyond Light's Criteria

C.3 Cell Count and Differential

C.4 Microbiology

C.5 Cytology

D. Imaging Modalities — Systematic Breakdown

D.1 Chest X-Ray (CXR) [1][3][5]

D.2 Ultrasound (USG) Thorax [1][2][3]

D.3 CT Thorax with Contrast [1][2][3]

D.4 PET-CT [2][3]

D.5 Decubitus Film [1][5]

E. Blood Tests — Supporting Investigations

F. Pleural Biopsy — When Fluid Analysis Is Not Enough [1][3]

G. Master Diagnostic Algorithm — Comprehensive Flowchart